• Biotech Pullback Makes Bargains Out Of Alexion, Flexion, Clovis, Tesaro, and Incyte

    Source: Forbes - World / 28 Nov 2017 12:01:22   America/New_York

    After a very strong year, the biotech sector has suffered an 8% pullback over the past 5 weeks. Todd Hagopian, whose biotech portfolio is up 38% this year, believes that the recent pullback has created bargains in Alexion, Flexion, Clovis, Tesaro, and Incyte. https://www.forbes.com/sites/kenkam/2017/11/28/biotech-pullback-makes-bargains-out-of-alexion-flexion-clovis-tesaro-and-incyte/
Share on,